Boston Medical Center Concussion Clinic, Ryan Center for Sports Medicine & Rehabilitation at Boston University
Boston, Massachusetts, 02215, United States
Location status: Recruiting
NCT Number: NCT06142435
Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 60 TBI patients and 20 controls.
Interested in participating?
Request Info18 year–45 year
All sexes
Observational
Boston, Massachusetts, 02215, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
HITT device to scan the eyes of participants up to 3 times (~45 seconds each) at the time of admittance to study. The participant is to place the chin in the chin-rest and fixate on the illuminated light on the device.
Other names: HITT
Time frame: 1 day
Patients who present with suspected TBI to the clinic will have their eyes scanned to identify whether the HITT device can accurately identify patients with TBI.
Time frame: 14 days
Patients who present with suspected TBI to the clinic and had initially been tested for TBI detection will receive a second set of scans at 2 weeks to identify whether the HITT device can accurately identify patients with TBI.
Time frame: 30 days
Patients who present with suspected TBI to the clinic and had initially been tested for TBI detection will receive a second set fo scans at one month to identify whether the HITT device can accurately identify patients with TBI.
Interested in participating?
Request InfoRebiscan, Inc.
Industry
Mild Traumatic Brain Injury Identification and Monitoring Through Retional Scanning
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07749625
Brain Diseases, Brain Injuries
Dhaka, Bangladesh
View Trial DetailsNCT07782216
Brain Diseases, Brain Injuries
Pécs, Branya, Hungary
View Trial DetailsNCT07655310
Brain Diseases, Brain Injuries
Bursa, Turkey (Türkiye)
View Trial DetailsNCT05848297
Brain Diseases, Brain Injuries
Davis, California, United States
View Trial Details